These results, combined with previous data from other studies [27–30], suggest that reversing MT deficiency could potentially serve as a promising clinical treatment for addressing insufficient autophagy in POI. This evidence concerns the gene MCAT and hyperinsulinemic hypoglycemia, familial, 4.